Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-21

FDA Approved: OMIDRIA — Supplemental Application (Rayner Surgical Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OMIDRIA (phenylephrine and ketorolac) from Rayner Surgical Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omidria (phenylephrine/ketorolac intraocular solution)

Snippet

SUPPL AP for OMIDRIA (PHENYLEPHRINE AND KETOROLAC)